Ventures Fund I. Llc Lilly serves as Executive at Receptos, Inc., where they oversee executive responsibilities. Since joining the company, Ventures Fund I. Llc Lilly has executed 12 insider transactions totaling $14.7M, demonstrating a bullish approach to their equity position. Their most recent transaction on Jul 5, 2017 involved purchasing 250,000 shares valued at $3.8M.
Ventures Fund I. Llc Lilly currently holds 1,094,987 shares of Receptos, Inc. (RCPT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Ventures Fund I. Llc Lilly has been a net buyer of RCPT stock. They have purchased $14.7M and sold $0 worth of shares.
Ventures Fund I. Llc Lilly's most recent insider trade was on Jul 5, 2017, when they purchased 250,000 shares at $15.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Aug 16, 2016 | PTGX | $0 | Conversion | 630,541 | $N/A | Discretionary |
| Aug 16, 2016 | PTGX | $0 | Conversion | 206,896 | $N/A | Discretionary |
| Aug 16, 2016 | PTGX | $7.0M | Purchase | 583,333 | $12.00 | Discretionary |
| Aug 16, 2016 | PTGX | $0 | Conversion | 678,712 | $N/A | Discretionary |
| May 14, 2013 | RCPT | $2.0M | Purchase | 142,857 | $14.00 | Discretionary |
| May 14, 2013 | RCPT | $6.0M | Conversion | 1,152,039 | $5.25 | Discretionary |
| May 14, 2013 | RCPT | $5.2M | Conversion | 672,029 | $7.73 | Discretionary |
| May 14, 2013 | RCPT | $5.2M | Conversion | 672,029 | $7.73 | Discretionary |
| May 14, 2013 | RCPT | $6.0M | Conversion | 1,152,039 | $5.25 | Discretionary |
| May 14, 2013 | RCPT | $2.0M | Purchase | 142,857 | $14.00 | Discretionary |